Fospropofol Intravenous and Insulin Glargine (U-100) Cartridge Systems and Pens
Determining the interaction of Fospropofol Intravenous and Insulin Glargine (U-100) Cartridge Systems and Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fospropofol
Brand name:
Synonyms: Fospropofol (Intravenous)
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fospropofol Intravenous-Insulin Glargine (U-100) Vials
- Fospropofol Intravenous-Insulin Glargine (U-300) Pens
- Fospropofol Intravenous-Insulin glargine and lixisenatide
- Fospropofol Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Fospropofol Intravenous-Insulin glargine, recombinant Subcutaneous
- Fospropofol Intravenous-Insulin glulisine
- Insulin Glargine (U-100) Cartridge Systems and Pens-Fosrenol
- Insulin Glargine (U-100) Cartridge Systems and Pens-Fosrenol (Lanthanum Chewable Tablets)
- Insulin Glargine (U-100) Cartridge Systems and Pens-Fosrenol (Lanthanum Powder)
- Insulin Glargine (U-100) Cartridge Systems and Pens-Fostamatinib
- Insulin Glargine (U-100) Cartridge Systems and Pens-Fostamatinib disodium
- Insulin Glargine (U-100) Cartridge Systems and Pens-Fosteum